Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...

Q4 2024 Management View CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency for the full year, excluding COVID-related revenues. Adjusted diluted EPS ...

We wrap up our coverage of the markets and the week. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — IQVIA Holdings Inc. (IQV) on Thursday reported fourth-quarter profit of $437 million. On a per-share basis, the Durham, North Carolina-based company said it had ...

While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) ...

DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, ...

The company reaffirms its 2025 outlook of revenue growth at constant currency ex-COVID of 4 to 7% Adjusted EBITDA margin expansion of up to 20 ...

Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...

IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...